ABHD4 and ovarian cancer: ABHD4 is a novel regulator of anoikis sensitivity because ABHD4 knockdown could inhibit anoikis in prostate cells and reduce anoikis sensitivity in nasopharyngeal and ovarian cancer cells, while the overexpression of ABHD4 increased anoikis sensitivity [49].